How to Buy Contineum Therapeutics Stock
Contineum Therapeutics Inc
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need.
Contineum Therapeutics stock last closed at $4.41, down 2% from the previous day, and has decreased 72.44% in one year. It has overperformed other stocks in the Biotechnology industry by 0.05 percentage points. Contineum Therapeutics stock is currently +14.55% from its 52-week low of $3.85, and -79.95% from its 52-week high of $22.00.
As of Apr 29, 2025, there are 25.87M shares of CTNM outstanding. The market capitalization of CTNM is $114.09M. In the past 24 hours, 43,578 CTNM shares were traded.
How to Buy Contineum Therapeutics Stock
Wondering how to invest in Contineum Therapeutics stock? Here's how.
- Figure out where to buy Contineum Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Contineum Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Choose your payment method and add your details.
- Research Contineum Therapeutics stock: The Contineum Therapeutics ticker symbol is CTNM. Is Contineum Therapeutics stock a good investment? Should you buy shares of CTNM? How do CTNM's underlying business fundamentals look? Do top analysts think Contineum Therapeutics is a good buy? Why has CTNM's stock price moved recently? (Hint: Our stock market research tools can help you figure out if CTNM is a good stock to buy).
- Place your CTNM purchase: Decide if you will purchase CTNM shares at the current market price or use a limit order to buy CTNM shares at a given price.
- Watch your investment in CTNM: Create a watchlist to get the latest news on your investment in Contineum Therapeutics shares.
Step 1: Figure out where to buy Contineum Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy CTNM shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you can invest in CTNM stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start your new trading account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've created your account on our top ranked stock trading app, you can securely and quickly fund your account:
Watch the walkthrough below to see the process of transferring funds into your investment account.
Step 4: Research Contineum Therapeutics stock
Once you have identified the best place to buy Contineum Therapeutics stock, it's very important to research their stock prior to investing, so you can wrap your head around the risk and upside.
Contineum Therapeutics stock data
CTNM Overview
WallStreetZen was designed to help everyday investors do better fundamental analysis.
You can see all of the due diligence checks on CTNM's stock page.
How is CTNM stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CTNM's intrinsic value.
Using relative valuations methods:
- CTNM may be undervalued based on its P/B ratio of 0.58x, relative to Biotechnology industry P/B ratio of 4.37x
You can access more valuation analysis on CTNM's stock here.
CTNM Financials at a glance
Passed Health Checks:
- CTNM has a low debt to equity ratio of 0.08.
- There are more short-term assets than long-term liabilities on the CTNM balance sheet.
- CTNM has cash burn of 33339000. It has sufficient cash and short-term investments to cover this for at least one year.
- CTNM has $204.76M in cash and short term investments. This is enough to cover its annual cash burn of $33.34M.
- There are more short-term assets than short-term liabilities on the CTNM balance sheet.
Is it a good time to buy CTNM stock, according to analysts?
Out of 4 Wall Street analysts who give ratings on CTNM, the consensus analyst rating on Contineum Therapeutics is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Contineum Therapeutics stock forecast page.
CTNM Momentum
CTNM Growth Metrics
Last year, CTNM revenue was $0.00. Over the past one years, CTNM's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 45.47%.
Dig into CTNM's earnings and revenue performance here.
Latest Insiders Trades at CTNM
In the past year, insiders at CTNM have bought more shares than they have sold.
Daniel S. Lorrain, Chief Scientific Officer of CTNM, was the latest CTNM insider to sell. They sold $16,177.17 worth of CTNM stock on Nov 25, 2024.
Learn more about who owns CTNM shares here.
Can I get consistent income from CTNM stock?
No, Contineum Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about CTNM
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your CTNM purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want additional assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Watch your investment in CTNM
Now that you own some CTNM shares, you'll want to keep up with your shares.
Add CTNM to a watchlist to track the latest developments regarding your CTNM stock.
CTNM Feed
How to Buy Stock in Contineum Therapeutics
To summarize, here are the 6 steps to buy stock in Contineum Therapeutics:
- Figure out where to buy Contineum Therapeutics stock
- Create a brokerage account
- Fund your brokerage account
- Research Contineum Therapeutics stock
- Place your CTNM purchase
- Watch your investment in CTNM
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your investment in Contineum Therapeutics, click the button below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.